keyword
MENU ▼
Read by QxMD icon Read
search

Rapid deployment aortic valve

keyword
https://www.readbyqxmd.com/read/28374618/the-economic-value-of-rapid-deployment-aortic-valve-replacement-via-full-sternotomy
#1
Matt Moore, Glenn R Barnhart, W Randolph Chitwood, John A Rizzo, Candace Gunnarsson, Swetha R Palli, Eugene A Grossi
AIM: To compare the economic value of EDWARDS INTUITY Elite™ (EIE) valve system for rapid-deployment aortic valve replacement (RDAVR) in a full sternotomy (FS) approach (EIE-FS-RDAVR) versus FS-AVR using conventional stented bioprosthesis. DATA & METHODS: A simulation model to compare each treatment's 30-day inpatient utilization and complication rates utilized: clinical end points obtained from the TRANSFORM trial patient subset (EIE-FS-RDAVR) and a best evidence review of the published literature (FS-AVR); and costs from the Premier database and published literature...
April 4, 2017: Journal of Comparative Effectiveness Research
https://www.readbyqxmd.com/read/28369288/rapid-deployment-aortic-valve-replacement-for-severe-aortic-stenosis-1-year-outcomes-in-150-patients%C3%A2
#2
Alexis Theron, Eleonore Ravis, Dominique Grisoli, Nicolas Jaussaud, Pierre Morera, Pascal Candolfi, Jana Boleckova, David Lagier, Cecile Amanatiou, Lyna Messous, Vlad Gariboldi, Frederic Collart
OBJECTIVES: This study aimed to evaluate the safety and effectiveness of rapid-deployment aortic valve replacement (RDAVR) for severe aortic stenosis (AS). METHODS: All consecutive patients with severe AS who underwent RDAVR with the EDWARDS INTUITY bioprosthesis were prospectively included in a single-centre, cohort study between July 2012 and April 2015. Clinical examination and transthoracic echocardiography were performed preoperatively and at 1-month and 1-year follow-up...
March 23, 2017: Interactive Cardiovascular and Thoracic Surgery
https://www.readbyqxmd.com/read/28361580/rapid-deployment-or-transcatheter-aortic-valves-in-intermediate-risk-patients
#3
Piergiorgio Bruno, Alessandro Di Cesare, Marialisa Nesta, Federico Cammertoni, Andrea Mazza, Lazzaro Paraggio, Raphael Rosenhek, Francesco Burzotta, Filippo Crea, Carlo Trani, Massimo Massetti
Background Transcatheter aortic valve implantation and rapid-deployment aortic valve replacement represent two emerging therapies for patients with intermediate surgical risk and severe aortic stenosis. However, head-to-head comparisons between such novel therapies are lacking. Methods Severe aortic stenosis patients with intermediate surgical risk treated with rapid-deployment valve replacement at our institution were identified and compared with a propensity-matched population of patients who underwent transcatheter aortic valve replacement...
January 1, 2017: Asian Cardiovascular & Thoracic Annals
https://www.readbyqxmd.com/read/28335899/percutaneous-plug-based-arteriotomy-closure-device-for-large-bore-access-a-multicenter-prospective-study
#4
Nicolas M Van Mieghem, Azeem Latib, Jan van der Heyden, Lennart van Gils, Joost Daemen, Todd Sorzano, Jurgen Ligthart, Karin Witberg, Thom de Kroon, Nathaniel Maor, Antonio Mangieri, Matteo Montorfano, Peter P de Jaegere, Antonio Colombo, Gary Roubin
OBJECTIVES: The authors sought to study the safety and efficacy of the MANTA Vascular Closure Device (VCD), a novel collagen-based technology dedicated to closure of large-bore arteriotomies. BACKGROUND: Novel transfemoral therapeutic interventions requiring large-bore catheters have become valid minimally invasive options but have inherent access management challenges. To date, no dedicated vascular closure devices exist for large arteriotomies. METHODS: A prospective, single-arm clinical investigation enrolling patients who underwent elective percutaneous interventions with large-bore catheters and planned percutaneous arteriotomy closure in 3 European institutions...
March 27, 2017: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/28288887/transapical-endovascular-repair-of-thoracic-aortic-pathology
#5
Takashi Murakami, Shinsuke Nishimura, Mitsuharu Hosono, Yoshitsugu Nakamura, Etsuji Sohgawa, Yukimasa Sakai, Toshihiko Shibata
BACKGROUND: Alternative access for thoracic endovascular aortic repair (TEVAR) has been explored for patients with unsuitable femoral and iliac access, but few cases of transapical access have been described. We report our experience with transapical access for various aortic pathologies. METHODS: We reviewed 6 cases undergoing transapical access for endovascular repair of thoracic aortic pathology between December 2013 and August 2015. Five patients had an aortic arch aneurysm and 1 patient presented with Stanford type A subacute aortic dissection...
March 10, 2017: Annals of Vascular Surgery
https://www.readbyqxmd.com/read/28219552/unusual-gastrointestinal-bleeding-after-sutureless-aortic-valve-replacement-a-word-of-caution
#6
Jules Iquille, Joseph Nader, Eric Colpart, Thierry Caus
We report the clinical case of a male patient who presented, after an aortic valve replacement with a rapid deployment bioprosthesis, a Heyde-like syndrome, secondary to a moderate aortic paravalvular leakage. All the digestive and hematologic investigations confirmed the diagnosis. A redo surgery to fill the paravalvular gap was accomplished and the postoperative course was uneventful, with a normalization of the biological parameters. To our knowledge, this is the first described case of such a complication with the new generation of sutureless bioprosthesis...
March 2017: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/28073791/rapid-deployment-aortic-replacement-radar-registry-in-spain-a-protocol
#7
Victor Bautista-Hernandez, Natalia Cal-Purriños, Jose M Arribas-Leal, Manuel Carnero-Alcazar, Jose F Gutierrez-Diez, Jose J Cuenca-Castillo
INTRODUCTION: Rapid deployment valves (RDV) represent a newly introduced approach to aortic valve replacement which facilitates surgical implantation and minimally invasive techniques, shortens surgical times and shows excellent haemodynamic performance. However, evidence on their safety, efficacy and potential complications is mostly fitted with small-volume and retrospective studies. Moreover, no current guidelines exist. To improve our knowledge on this technology, The Rapid Deployment Aortic Replacement (RADAR) Registry will be established across Spain with the aim of assessing RDV outcomes in the real-world setting...
January 10, 2017: BMJ Open
https://www.readbyqxmd.com/read/28043451/transapical-cannulation-through-a-transcatheter-aortic-valve-implantation-valve-a-novel-approach-for-cardiogenic-collapse
#8
Louis Philippe Tremblay, Claudia Cote, Marc P Pelletier
We report a case of rescue bypass cannulation of the ventricular apex during a transapical transcatheter aortic valve implantation procedure in a patient with peripheral vascular disease not amenable to peripheral cannulation. Following rapid pacing and deployment of the transcatheter valve, cardiac function did not recover. The arterial cannula was inserted through the left ventricular apex, at the site of the transapical sheath, and advanced across the prosthetic valve, allowing for rapid initiation of cardiopulmonary bypass...
July 2016: Seminars in Thoracic and Cardiovascular Surgery
https://www.readbyqxmd.com/read/28018816/rapid-deployment-aortic-valve-replacement-after-previous-mechanical-valve-implantation
#9
Markus Schlömicher, Peter Lukas Haldenwang, Vadim Moustafine, Britta Wolf, Peter Zahn, Matthias Bechtel, Justus Thomas Strauch
Recent studies report a reproducible reduction of myocardial ischemic and cardiopulmonary bypass times along with excellent hemodynamics and low rates of paravalvular leakage for rapid-deployment valves. A 68-year-old female patient with aortic stenosis and a mechanical mitral valve which was implanted in 2006 received rapid-deployment aortic valve replacement. The procedure could be performed with a cross-clamp time of 45 minutes and a cardiopulmonary bypass time of 60 minutes. Postoperative course was uncomplicated and the patient was discharged to the referring hospital on postoperative day 8...
December 2016: Thoracic and Cardiovascular Surgeon Reports
https://www.readbyqxmd.com/read/27989072/how-to-do-it-implantation-technique-for-newer-generation-sutureless-rapid-deployment-aortic-valve-replacement
#10
Nikhil Prakash Patil, Fabio Falconieri, John Pepper, Toufan Bahrami
'Sutureless' or rapid-deployment (RD) aortic valve replacement (AVR) is an emerging alternative to standard AVR in elderly high-risk surgical patients. Here, the authors describe their implantation technique for the newer-generation Edwards INTUITY-Elite® valve (Edwards Lifesciences, Irvine, CA, USA), a balloon-expandable stented trileaflet bovine pericardial bioprosthesis that received CE Mark European approval in April 2014.
March 2016: Journal of Heart Valve Disease
https://www.readbyqxmd.com/read/27977305/what-is-the-role-of-sutureless-aortic-valves-in-today-s-armamentarium
#11
REVIEW
Dimos Karangelis, Amine Mazine, Apostolos Roubelakis, Christos Alexiou, Socrates Fragoulis, C David Mazer, Bobby Yanagawa, David Latter, Daniel Bonneau
Sutureless and rapid-deployment aortic bioprostheses represent an emerging and promising technology for the treatment of aortic valve stenosis. Unlike traditional aortic bioprostheses, these devices are not hand-sewn, thus allowing a significant reduction in operative times, while facilitating minimally invasive surgery and complex cardiac interventions. Sutureless aortic valve replacement represents a less invasive treatment option and an excellent alternative to conventional aortic valve replacement in elderly and higher risk patients...
February 2017: Expert Review of Cardiovascular Therapy
https://www.readbyqxmd.com/read/27972042/the-economic-value-of-rapid-deployment-aortic-valve-replacement-via-full-sternotomy
#12
M Moore, G R Barnhart, W R Chitwood, J A Rizzo, C Gunnarsson, S R Palli, E A Grossi
No abstract text is available yet for this article.
November 2016: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://www.readbyqxmd.com/read/27873180/pledget-armed-sutures-affect-the-haemodynamic-performance-of-biologic-aortic-valve-substitutes-a-preliminary-experimental-and-computational-study
#13
Claudio Capelli, Chiara Corsini, Dario Biscarini, Francesco Ruffini, Francesco Migliavacca, Alfred Kocher, Guenther Laufer, Andrew M Taylor, Silvia Schievano, Martin Andreas, Gaetano Burriesci, Claus Rath
Surgical aortic valve replacement is the most common procedure of choice for the treatment of severe aortic stenosis. Bioprosthetic valves are traditionally sewed-in the aortic root by means of pledget-armed sutures during open-heart surgery. Recently, novel bioprostheses which include a stent-based anchoring system have been introduced to allow rapid implantation, therefore reducing the duration and invasiveness of the intervention. Different effects on the hemodynamics were clinically reported associated with the two technologies...
March 2017: Cardiovascular Engineering and Technology
https://www.readbyqxmd.com/read/27866023/direct-and-adjusted-indirect-comparisons-of-perioperative-mortality-after-sutureless-or-rapid-deployment-aortic-valve-replacement-versus-transcatheter-aortic-valve-implantation
#14
Hisato Takagi, Tomo Ando, Takuya Umemoto
OBJECTIVES: To determine which procedure, aortic valve replacement (AVR) with a sutureless or rapid-deployment prosthesis (SL-AVR) or transcatheter aortic valve implantation (TAVI), achieves better perioperative survival for severe aortic stenosis (AS), we conducted direct-comparison meta-analyses (DC-MAs) and an adjusted indirect-comparison meta-analysis (IDC-MA). METHODS: We searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials through April 2016...
February 1, 2017: International Journal of Cardiology
https://www.readbyqxmd.com/read/27817951/transform-multicenter-experience-with-rapid-deployment-edwards-intuity-valve-system-for-aortic-valve-replacement-us-clinical-trial-performance-of-a-rapid-deployment-aortic-valve
#15
Glenn R Barnhart, Kevin D Accola, Eugene A Grossi, Y Joseph Woo, Mubashir A Mumtaz, Joseph F Sabik, Frank N Slachman, Himanshu J Patel, Michael A Borger, H Edward Garrett, Evelio Rodriguez, Patrick M McCarthy, William H Ryan, Francis G Duhay, Michael J Mack, W Randolph Chitwood
BACKGROUND: The TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) trial (NCT01700439) evaluated the performance of the INTUITY rapid deployment aortic valve replacement (RDAVR) system in patients with severe aortic stenosis. METHODS: TRANSFORM was a prospective, nonrandomized, multicenter (n = 29), single-arm trial. INTUITY is comprised of a cloth-covered balloon-expandable frame attached to a Carpentier-Edwards PERIMOUNT Magna Ease aortic valve...
October 15, 2016: Journal of Thoracic and Cardiovascular Surgery
https://www.readbyqxmd.com/read/27744323/rapid-deployment-aortic-valve-replacement-in-the-setting-of-concomitant-mitral-valve-procedures
#16
Matthias Bechtel, Markus Schlömicher, Vadim Moustafine, Justus Thomas Strauch
The technique of rapid deployment aortic valve implantation in patients with concomitant mitral valve surgery is described and the outcome of our first 25 patients reported.
April 1, 2017: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/27696659/transcatheter-aortic-valve-implantation-with-a-sapien-3-commander-20-mm-valves-in-patients-with-degenerated-19-mm-bioprosthetic-aortic-valve
#17
Pranav Loyalka, Angelo Nascimbene, Michael Schechter, Marija Petrovic, Ajay Sundara Raman, Igor D Gregoric, Biswajit Kar
INTRODUCTION: Transcatheter aortic valve implantation (TAVI) in patients with degenerated bioprosthetic aortic valve has been successfully performed as an alternative to surgery. We describe our initial experience of valve-in-valve TAVI in five patients, using new generation Edwards Sapien 3 transcatheter heart valves implanted into degenerated 19 mm bioprosthetic valves. 20-mm Edwards S3 valves were offered for compassionate use. All patients had significant aortic valve stenosis. METHODS AND RESULTS: The main vascular access was achieved and pre-closed with two Proglide closure devices in one patient and Prostar closure devices in four patients...
October 3, 2016: Catheterization and Cardiovascular Interventions
https://www.readbyqxmd.com/read/27645962/redo-after-failure-of-aortic-homografts-with-a-rapid-deployment-valve
#18
Tommaso Hinna Danesi, Giuseppe Minniti, Giovanni Domenico Cresce, Alessandro Favaro, Paolo Magagna, Stefano Auriemma, Matteo Micciolo, Salvo Mirone, Elvio Polesel, Loris Salvador
Homograft implantation in the aortic position was a common approach for full root aortic surgical procedures in the early 2000s. Reintervention after degeneration of such homografts remains a challenge. We report two cases of successful implantation of the Edwards Intuity Elite rapid deployment valve into patients with degeneration of existing aortic homograft implants leading to severe aortic regurgitation.
October 2016: Annals of Thoracic Surgery
https://www.readbyqxmd.com/read/27640024/calcification-of-the-aortic-valve-and-mitral-apparatus-location-quantification-and-implications-for-device-selection
#19
Jonathon Leipsic, Philipp Blanke
The treatment of both aortic and now mitral valvular disease has been transformed through transcatheter valvular interventions. TAVR has rapidly become the treatment of choice for symptomatic severe aortic stenosis in both high, and now intermediate-risk patients. Building upon this success the last two years have seen the clinical introduction of transcatheter mitral valve replacement (TMVR), with a number of devices being utilised in first-in-man and feasibility studies. These experiences have helped determine the anatomical requirements and specifications that enable successful device deployment and avoidance of complications...
September 18, 2016: EuroIntervention
https://www.readbyqxmd.com/read/27582765/aortic-valve-replacement-with-sutureless-and-rapid-deployment-aortic-valve-prostheses
#20
Paolo Berretta, Marco Di Eusanio
Aortic valve stenosis is the most common valve disease in the western world. Over the past few years the number of aortic valve replacement (AVR) interventions has increased with outcomes that have been improved despite increasing age of patients and increasing burden of comorbidities. However, despite such excellent results and its well-established position, conventional AVR has undergone great development over the previous two decades. Such progress, by way of less invasive incisions and use of new technologies, including transcatheter aortic valve implantation and sutureless valve prostheses, is intended to reduce the traumatic impact of the surgical procedure, thus fulfilling lower risk patients' expectations on the one hand, and extending the operability toward increasingly high-risk patients on the other...
September 2016: Journal of Geriatric Cardiology: JGC
keyword
keyword
113401
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"